Cue Biopharma, Inc. (CUE)
NASDAQ·Healthcare·Biotechnology
$20.50
+9.45%
Mkt Cap $200.93M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$83.00
Range $83.00 – $83.00
Implied Upside
+304.9%
Consensus $83.00 vs current $20.50
NASDAQ·Healthcare·Biotechnology
$20.50
+9.45%
Mkt Cap $200.93M
No recent rating data.
Price Target (5 analysts)
$83.00
Range $83.00 – $83.00
+304.9%
Consensus $83.00 vs current $20.50